EnteroMedics' Other Investors

EnteroMedics raised a round of funding on , . Investors include Charter Life Sciences.

EnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. vBloc® is a firs…

Articles about EnteroMedics' Other Investors: